China NMPA Inspection - Weifang 3D Biotechnology Group Co., Ltd. - January 08, 2020
China NMPA unannounced inspection for Weifang 3D Biotechnology Group Co., Ltd. published January 08, 2020. The National Medical Products Administration (NMPA) conducted an unannounced inspection of Weifang Sanwei Biotechnology Group Co., Ltd., leading to an
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
China NMPA unannounced inspection for Weifang 3D Biotechnology Group Co., Ltd. published January 08, 2020. The National Medical Products Administration (NMPA) conducted an unannounced inspection of Weifang Sanwei Biotechnology Group Co., Ltd., leading to an
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Inspection Date
Unknown Date
Product Type
devices
ID: 28289e73-9b13-4cd2-a18a-9a848c0f1448
View on DashboardTransform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox